261Y000236 - Ipratropium Ampoules for Nebulization 250 mcg

This tender, identified by the reference 261Y000236, concerns the procurement of Ipratropium bromide ampoules specifically formulated for nebulization, with each ampoule containing 250 mcg of the active pharmaceutical ingredient. Ipratropium bromide is a bronchodilator commonly used in the management of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. The medication is administered via a nebulizer, a device that converts the liquid medication into a fine mist for inhalation directly into the lungs. This procurement is likely intended to ensure a consistent supply of this essential medication for healthcare facilities, potentially for patient treatment in hospitals, clinics, or emergency services. The tender specifies the exact dosage and form of the medication, indicating a need for a precise pharmaceutical product to meet clinical requirements. Further details regarding the quantity, delivery schedule, and specific quality standards are expected to be outlined in the full tender documentation, which will guide potential suppliers in submitting their bids for this essential medical supply.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 296.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.